Compounds > cyfluthrin
Page last updated: 2024-08-26

cyfluthrin and Disease Models, Animal

cyfluthrin has been researched along with Disease Models, Animal in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's6 (85.71)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Machemer, LH; Pauluhn, J1
Kim, MK; Nicolau, DP; Nightingale, CH; Tessier, PR; Xuan, D; Ye, M; Zhou, W1
Banevicius, MA; Capitano, B; Maglio, D; Nicolau, DP; Nightingale, CH1
Azoulay-Dupuis, E; Barau, C; Bédos, JP; Fantin, B; Mohler, J1
Araujo, FG; Craft, JC; Khan, AA; Remington, JS1
Alder, JD; Ewing, P; Flamm, RK; Hernandez, L; Jarvis, K; Ma, Z; Meulbroek, J; Mitten, MJ; Mollison, K; Nilius, AM; Nukkala, M; Oleksijew, A; Or, YS; Paige, L; Tovcimak, A1
Edelstein, MA; Edelstein, PH; Higa, F1

Other Studies

7 other study(ies) available for cyfluthrin and Disease Models, Animal

ArticleYear
Assessment of pyrethroid-induced paraesthesias: comparison of animal model and human data.
    Toxicology letters, 1998, Volume: 96-97

    Topics: Administration, Inhalation; Adult; Aerosols; Animals; Disease Models, Animal; Humans; Insecticides; Male; Nitriles; Paresthesia; Predictive Value of Tests; Pyrethrins; Rats; Rats, Wistar; Respiratory Tract Diseases; Risk Assessment; Stimulation, Chemical

1998
Bactericidal effect and pharmacodynamics of cethromycin (ABT-773) in a murine pneumococcal pneumonia model.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:10

    Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Azithromycin; Clindamycin; Disease Models, Animal; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Ketolides; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pneumonia, Pneumococcal; Streptococcus pneumoniae

2002
Bactericidal effect of cethromycin (ABT-773) in an immunocompetent murine pneumococcal pneumonia model.
    International journal of antimicrobial agents, 2003, Volume: 22, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Erythromycin; Female; Immunocompetence; Ketolides; Mice; Mice, Inbred CBA; Neutropenia; Neutrophils; Pneumonia, Pneumococcal; Streptococcus pneumoniae

2003
Efficacy of cethromycin, a new ketolide, against Streptococcus pneumoniae susceptible or resistant to erythromycin in a murine pneumonia model.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:9

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Erythromycin; Ketolides; Mice; Pneumonia, Pneumococcal; Streptococcus pneumoniae

2006
Ketolide ABT-773 is active against Toxoplasma gondii.
    The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:3

    Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Erythromycin; Female; Humans; Ketolides; Mice; Toxoplasma; Toxoplasmosis

2000
Efficacies of ABT-773, a new ketolide, against experimental bacterial infections.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:9

    Topics: Animals; Bacterial Infections; Disease Models, Animal; Drug Resistance, Microbial; Erythromycin; Female; Haemophilus Infections; Haemophilus influenzae; Ketolides; Listeriosis; Lung Diseases; Male; Mice; Rats; Rats, Sprague-Dawley; Respiratory Tract Diseases; Staphylococcal Infections; Streptococcal Infections; Streptococcus pneumoniae; Treatment Outcome

2001
In vitro activity of ABT-773 against Legionella pneumophila, its pharmacokinetics in guinea pigs, and its use to treat guinea pigs with L. pneumophila pneumonia.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:10

    Topics: Animals; Colony Count, Microbial; Disease Models, Animal; Erythromycin; Guinea Pigs; Ketolides; Legionella pneumophila; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Treatment Outcome

2001